Literature DB >> 15533316

Intravitreal transplants of Schwann cells and fibroblasts promote the survival of axotomized retinal ganglion cells in rats.

Shengxiu Li1, Bing Hu, David Tay, Kwok-Fai So, Henry Ka-Fun Yip.   

Abstract

Schwann cells (SCs) are considered one of the major cellular components to maintain the integrity of the peripheral nervous system (PNS) neurons after injury. Intravitreal transplant of peripheral nerves or Schwann cells has been shown to enhance the regenerative ability of retinal ganglion cells (RGCs). In the present study, we compared the effects of intravitreal transplants of Schwann cells and fibroblasts, two major components of peripheral nerves, on the survival of retinal ganglion cells in adult rats after optic nerve (ON) transection. Purified Schwann cells and fibroblasts from neonatal sciatic nerves were injected into the vitreous body of adult rats. Three days after the injection, the optic nerves were transected intraorbitally. After 1 week or 1 month, surviving retinal ganglion cells were retrogradely labelled with Fluoro-Gold (FG) and the number of surviving retinal ganglion cells was counted. The retinas were further processed for 200-kDa neurofilament RT-97 immunohistochemistry. It was found that intravitreally injected- Schwann cells and -fibroblasts delayed the death of axotomized retinal ganglion cells for 1 week. In addition, in the animal group with 1 month survival time after optic nerve transection, those received a larger number of Schwann cells had more surviving retinal ganglion cells and more profusely ramified axonal processes near the optic disc. These findings reveal that both Schwann cells and fibroblasts isolated from the peripheral nerve can promote retinal ganglion cell survival after optic nerve transection, presumably by secreting neurotrophic factors. In addition, the data also demonstrate that Schwann cells could promote intraretinal axonal sprouting. Our findings demonstrate a remarkable glial source of neurotrophic factors with potential clinical applications, as autologous Schwann cells and fibroblasts can be feasibly obtained from peripheral nerves.

Entities:  

Mesh:

Year:  2004        PMID: 15533316     DOI: 10.1016/j.brainres.2004.09.038

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Impediments to eye transplantation: ocular viability following optic-nerve transection or enucleation.

Authors:  D Ellenberg; J Shi; S Jain; J-H Chang; H Ripps; S Brady; E R Melhem; F Lakkis; A Adamis; D-F Chen; R Ellis-Behnke; R S Langer; S M Strittmatter; D T Azar
Journal:  Br J Ophthalmol       Date:  2009-03-13       Impact factor: 4.638

2.  Concomitant optic nerve transection and chorioretinitis sclopetaria.

Authors:  Mehrdad Mohammadpour; Masoud Soheilian
Journal:  BMC Ophthalmol       Date:  2005-12-22       Impact factor: 2.209

3.  Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo.

Authors:  L Guo; B Davis; S Nizari; E M Normando; H Shi; J Galvao; L Turner; J Shi; M Clements; S Parrinello; M F Cordeiro
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

4.  Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Transection is Driven by Cellular Intravitreal Sciatic Nerve Grafts.

Authors:  Zubair Ahmed; Ellen L Suggate; Ann Logan; Martin Berry
Journal:  Cells       Date:  2020-05-27       Impact factor: 6.600

5.  Predegenerated Schwann cells--a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity.

Authors:  Adrian Smedowski; Xiaonan Liu; Marita Pietrucha-Dutczak; Iwona Matuszek; Markku Varjosalo; Joanna Lewin-Kowalik
Journal:  Sci Rep       Date:  2016-04-01       Impact factor: 4.379

6.  Intravitreal Co-Administration of GDNF and CNTF Confers Synergistic and Long-Lasting Protection against Injury-Induced Cell Death of Retinal Ganglion Cells in Mice.

Authors:  Simon Dulz; Mahmoud Bassal; Kai Flachsbarth; Kristoffer Riecken; Boris Fehse; Stefanie Schlichting; Susanne Bartsch; Udo Bartsch
Journal:  Cells       Date:  2020-09-11       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.